Top Markets
Coin of the day
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLN
Rangering i aksjer #37031
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the... ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.
Aksjekurs
$0.6
Sist synkronisert: 2024-08-14
Markedsverdi
$2.09M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
SG
Handel ASLAN Pharmaceuticals Limited (ASLN)

Kategori

Inntekter for ASLAN Pharmaceuticals Limited (ASLN)
Inntekter i Mar 2024 TTM: $-34.90M
Ifølge ASLAN Pharmaceuticals Limited sine nyeste økonomiske rapporter er selskapets nåværende resultat $-34.90M. I 2022 hadde selskapet et resultat på $-51.28M, en nedgang sammenlignet med resultatet i 2021, som var $-31.59M. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for ASLAN Pharmaceuticals Limited fra 2014 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $-34.90M -20.84%
2023 $-44.09M -14.03%
2022 $-51.28M 62.34%
2021 $-31.59M 86.14%
2020 $-16.97M -63.63%
2019 $-46.66M 10.64%
2018 $-42.17M 3.58%
2017 $-40.71M 352.17%
2016 $-9.00M -32.43%
2015 $-13.33M 80.95%
2014 $-7.36M 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$5.27B -15,214.03%
US
$1.95B -5,689.14%
NL
- -
CH
- -
KR
$3.01B -8,712.20%
BE